-transparent.png){kind=logo}
Ten analogues of the antibiotic sparsomycin were prepared and evaluated in several in vitro tests. Nine of them carry a modification at the hydroxymethylene group of the molecule, two have a disulfide bond instead of the S(O)-CH2-S moiety at the sulfur-containing side chain of the molecule. While the presence of the S-S group decreases the activity of the analogues in all the tests performed, the modification at the OH group has no deleterious effects on the activity when a polyphenylalanine synthesis assay is used in an Escherichia coli extract. The same modifications, however, diminish drastically the activity of the analogues when tested in a similar Saccharomyces cerevisiae extract. A polymerization system in the archaebacterium Halobacterium halobium extract behaves like the eukaryotic preparations. A discrepancy is also found between the results of the polymerization tests and those of the 'puromycin reaction' which is also less sensitive to the modified sparsomycin analogues. The results of cell growth inhibition tests in bacteria as well as in eukaryotic organisms agree only partially with the in vitro data.
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
November 1996,
The Journal of antibiotics,
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
March 1984,
Journal of medicinal chemistry,
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
January 1984,
Steroids,
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
July 1997,
Molecular pharmacology,
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
March 1991,
Molecular pharmacology,
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
December 2002,
Bioorganic & medicinal chemistry letters,
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
October 1973,
Antimicrobial agents and chemotherapy,
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
June 2013,
Bioorganic & medicinal chemistry letters,
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
October 2005,
Archives of toxicology,
E Lázaro, and
L A van den Broek, and
H C Ottenheijm, and
P Lelieveld, and
J P Ballesta
May 1976,
The Journal of organic chemistry,
